The global market for Syringes is estimated at US$15.2 Billion in 2023 and is projected to reach US$24.2 Billion by 2030, growing at a CAGR of 6.9% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
Technological advancements and product innovation are another major trend shaping the market`s trajectory. The development of safety syringes with retractable needles to minimize the risk of accidental needlesticks and the spread of infections is gaining traction. Pre-filled syringes have also emerged as a preferred choice due to their convenience, precise dosing, and reduced preparation time, especially for administering vaccines and biologics. The growth of biologic drugs, which require injectable delivery, supports market demand. Advances in drug formulations are enabling subcutaneous delivery, making at-home treatment feasible for chronic diseases such as autoimmune disorders and certain cancers. This has transformed how pharmaceutical companies approach treatment delivery, encouraging them to decide on the best delivery methods earlier in development. As a result, development processes are streamlined, reducing both costs and testing time. Additionally, the shift toward more eco-friendly, disposable syringes is gaining importance, as hospitals and clinics seek to minimize the environmental impact of medical waste.
Technological advancements and product innovation are another major trend shaping the market`s trajectory. The development of safety syringes with retractable needles to minimize the risk of accidental needlesticks and the spread of infections is gaining traction. Pre-filled syringes have also emerged as a preferred choice due to their convenience, precise dosing, and reduced preparation time, especially for administering vaccines and biologics. The growth of biologic drugs, which require injectable delivery, supports market demand. Advances in drug formulations are enabling subcutaneous delivery, making at-home treatment feasible for chronic diseases such as autoimmune disorders and certain cancers. This has transformed how pharmaceutical companies approach treatment delivery, encouraging them to decide on the best delivery methods earlier in development. As a result, development processes are streamlined, reducing both costs and testing time. Additionally, the shift toward more eco-friendly, disposable syringes is gaining importance, as hospitals and clinics seek to minimize the environmental impact of medical waste.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Prefilled Syringes segment, which is expected to reach US$10.6 Billion by 2030 with a CAGR of a 8.4%. The Disposable Safety Syringes segment is also set to grow at 6.8% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $4.1 Billion in 2023, and China, forecasted to grow at an impressive 11.4% CAGR to reach $5.7 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Syringes Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Syringes Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Syringes Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Company, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 101 Featured):
- Abbott Laboratories
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Cardinal Health
- Kawamoto Corporation
- Medline Industries Inc.
- Merit Medical Systems
- Nipro Medical Corporation
- Retractable Technologies
- Smiths Medical
- Terumo Corporation
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISSOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
SPAIN
RUSSIA
REST OF EUROPE
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned
- Abbott Laboratories
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Cardinal Health
- Kawamoto Corporation
- Medline Industries Inc.
- Merit Medical Systems
- Nipro Medical Corporation
- Retractable Technologies
- Smiths Medical
- Terumo Corporation
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 303 |
Published | November 2024 |
Forecast Period | 2023 - 2030 |
Estimated Market Value ( USD | $ 15.2 Billion |
Forecasted Market Value ( USD | $ 24.2 Billion |
Compound Annual Growth Rate | 6.9% |
Regions Covered | Global |
No. of Companies Mentioned | 11 |